Early brain cancer detection breakthrough
Early detection of brain cancer has moved one step closer, through a breakthrough by cancer diagnostics firm and University of Strathclyde spinout company Dxcover.
Aug 10, 2021
0
425
Early detection of brain cancer has moved one step closer, through a breakthrough by cancer diagnostics firm and University of Strathclyde spinout company Dxcover.
Aug 10, 2021
0
425
Researchers from the University of Portsmouth's Brain Tumour Research Centre of Excellence have identified molecules which are responsible for metastatic lung cancer cells binding to blood vessels in the brain.
Aug 3, 2017
0
96
Scientists have identified a gene mutation linked to the development of an aggressive form of brain cancer.
Jun 12, 2015
0
118
(Medical Xpress)—New research from the University of Adelaide has shown for the first time that the growth of brain tumours can be halted by a drug currently being used to help patients recover from the side effects of ...
Mar 18, 2013
0
0
Researchers at the University of Calgary's Hotchkiss Brain Institute (HBI) have made a discovery that could lead to better treatment for patients suffering from brain cancer.
Dec 8, 2013
0
1
Researchers in France may have discovered why some patients with a type of brain tumour have epileptic seizures.
Jul 14, 2014
0
0
The rate of children dying from cancer has dropped by 22 per cent in the last decade, according to new figures published by Cancer Research UK at the start of Children's Cancer Awareness Month.
Sep 1, 2014
0
0
(Medical Xpress)—Rare DNA faults in two genes have been strongly linked to bowel cancer by Oxford University researchers, who sequenced the genomes of people from families with a strong history of developing the disease.
Dec 24, 2012
0
0
Neuroblastoma is a childhood cancer, most commonly affecting children aged between two to three and can be fatal. Since the tumor cells resemble certain cells in the adrenal glands, a joint research group from MedUni Vienna's ...
May 7, 2021
0
108
Prolonged high dose use of the hormone drug cyproterone acetate is associated with an increased risk of developing a brain tumour, finds a study of over 250,000 women in France published by The BMJ today.
Feb 3, 2021
0
8